Skip to main content
Clinical Trials/CTRI/2024/07/069753
CTRI/2024/07/069753
Not yet recruiting
未知

Adverse Drug Reaction monitoring in Patients receiving Anti Tubercular ( ATT ) and Antiretroviral Therapy ( ART ) - NI

Dr Puneet Paliwal0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Puneet Paliwal
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Dr Puneet Paliwal

Eligibility Criteria

Inclusion Criteria

  • 1\.Cases of adverse drug reactions due to anti\-tubercular and antiretroviral therapy.
  • 2\.Patients more than 18 years with Pulmonary TB, EPTB or disseminated TB.

Exclusion Criteria

  • 1\.Cases having incompletely filled adverse drug reaction details will be excluded from the study.
  • 2\.Treatment defaulters or death within 15 days of ATT.
  • 3\.Any other diagnosis other than TB after starting treatment.
  • 4\.Cases who do not give consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials